Skip to main content
Fig. 2 | Health and Quality of Life Outcomes

Fig. 2

From: Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies

Fig. 2

Study Design for the Combination Therapy Study. I Injectable Diabetes Medication Questionnaire - Japanese version; LV30 follow-up visit 30 days after last study visit; P Perceptions About Medications-Diabetes 21 Questionnaire - Japanese version; PRO patient-reported outcomes; SU sulfonylurea; TV telephone visit

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us